1. Home
  2. NEXT vs HTFL Comparison

NEXT vs HTFL Comparison

Compare NEXT & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NextDecade Corporation

NEXT

NextDecade Corporation

HOLD

Current Price

$7.73

Market Cap

2.2B

Sector

Energy

ML Signal

HOLD

HTFL

Heartflow Inc.

HOLD

Current Price

$32.82

Market Cap

2.5B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
NEXT
HTFL
Founded
2010
2007
Country
United States
United States
Employees
N/A
843
Industry
Oil & Gas Production
Sector
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.5B
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
NEXT
HTFL
Price
$7.73
$32.82
Analyst Decision
Hold
Strong Buy
Analyst Count
2
5
Target Price
$8.00
$38.20
AVG Volume (30 Days)
2.3M
1.1M
Earning Date
05-01-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$27.66
Revenue Next Year
N/A
$23.55
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.75
$20.13
52 Week High
$12.12
$41.22

Technical Indicators

Market Signals
Indicator
NEXT
HTFL
Relative Strength Index (RSI) 42.48 63.05
Support Level $6.53 $32.09
Resistance Level $8.93 $37.93
Average True Range (ATR) 0.40 1.99
MACD -0.08 0.37
Stochastic Oscillator 9.58 80.62

Price Performance

Historical Comparison
NEXT
HTFL

About NEXT NextDecade Corporation

NextDecade Corp is a Houston-based energy company engaged in construction and development activities related to the liquefaction of natural gas, the sale of LNG, and the capture and storage of CO2 emissions. The group is constructing and developing a natural gas liquefaction and export facility located in the Rio Grande Valley near Brownsville, Texas (the Rio Grande LNG Facility). It also engaged in NEXT Carbon Solutions, advancing proprietary processes to lower the cost of utilizing carbon capture and storage (CCS) and help companies reduce their emissions and achieve their clean energy goals.

About HTFL Heartflow Inc.

HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.

Share on Social Networks: